LOLLI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.064
EU - Europa 7.754
AS - Asia 1.588
AF - Africa 69
SA - Sud America 8
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.042
RU - Federazione Russa 2.501
IT - Italia 1.155
PL - Polonia 1.153
SE - Svezia 837
IE - Irlanda 812
SG - Singapore 533
HK - Hong Kong 393
UA - Ucraina 383
DE - Germania 307
CN - Cina 302
FI - Finlandia 185
GB - Regno Unito 161
IN - India 135
CH - Svizzera 131
JO - Giordania 113
TR - Turchia 48
CI - Costa d'Avorio 44
VN - Vietnam 30
ES - Italia 27
FR - Francia 27
NL - Olanda 27
AT - Austria 23
KR - Corea 21
CA - Canada 19
SC - Seychelles 19
BE - Belgio 11
CL - Cile 5
PH - Filippine 5
AU - Australia 4
JP - Giappone 4
ZA - Sudafrica 4
BR - Brasile 3
CZ - Repubblica Ceca 3
EU - Europa 3
MX - Messico 3
PT - Portogallo 3
MU - Mauritius 2
NZ - Nuova Zelanda 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
BG - Bulgaria 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
RS - Serbia 1
Totale 20.492
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.864
Fairfield 1.410
Warsaw 1.151
Chandler 834
Dublin 808
Woodbridge 659
Ashburn 617
Seattle 577
Jacksonville 548
Cambridge 524
Wilmington 471
Houston 454
Singapore 405
Lawrence 268
Altamura 267
Princeton 221
Hong Kong 216
Ann Arbor 204
Florence 176
Beijing 148
Boston 143
Bern 127
Mumbai 125
Boardman 118
Medford 102
Buffalo 101
Moscow 100
San Diego 77
Rome 62
Shanghai 59
Milan 58
Kent 47
Falls Church 45
Abidjan 44
Norwalk 43
Izmir 39
Los Angeles 29
Verona 27
New York 24
Barcelona 22
Bologna 22
Frankfurt Am Main 22
Vienna 22
Auburn Hills 21
Hillsboro 21
Seoul 21
Andover 20
Redwood City 19
Dong Ket 18
Yubileyny 18
Helsinki 16
Munich 16
Toronto 16
West Jordan 15
Ravenna 14
London 13
Arezzo 11
Brussels 10
Genoa 10
Turin 10
Laurel 9
Padova 9
Phoenix 9
Saint Petersburg 9
Siena 9
Palermo 8
Torino 8
Osio Sotto 7
Bremen 6
Castelliri 6
Lappeenranta 6
Napoli 6
Pisa 6
Amsterdam 5
Fontebuona 5
Forlì 5
Redmond 5
Arnsberg 4
Castellammare di Stabia 4
Dearborn 4
Detroit 4
Ludhiana 4
Manfredonia 4
Mariglianella 4
Pavia 4
Pescara 4
Rosolini 4
Salerno 4
Urbino 4
Andria 3
Bari 3
Busto Arsizio 3
Casalecchio di Reno 3
Casorezzo 3
Chiswick 3
Frankfurt am Main 3
Hangzhou 3
Kilburn 3
Lucca 3
Monza 3
Totale 13.748
Salva come PNG Salva come JPEG
Nome #
The Italian version of Edinburgh Handedness Inventory: Translation, transcultural adaptation, and validation in healthy subjects 281
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. 277
Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae 266
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. 259
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. 253
Cerebrospinal fluid analysis and the determination of oligoclonal bands 253
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis 250
O034. Type of pain and onabotulinumtoxin-A in chronic migraine: four years of follow-up 232
Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. 226
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop 166
10. Somatosensory Evoked Potentials as predictors of evolution toward brain death in comatose patients after acquired brain injury 157
Data on multimodal approach for early poor outcome (Cerebral Performance Categories 3-5) prediction after cardiac arrest 151
Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barre syndrome. 149
Glycopeptide-Based Antibody Detection in Multiple Sclerosis by Surface Plasmon Resonance 144
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors 144
B cells and multiple sclerosis 141
Critical illness-polyneuromyopathy: functional impact after severe Acquired Brain Injuries 141
Post-translationally modified peptides efficiently mimicking neo-antigens: A challenge for theragnostics of autoimmune diseases. 139
Predictive patterns of sensory evoked potentials in comatose brain injured patients evolving to brain death 137
Linee guida per l'analisi di base del liquor (Associazione Italiana di Neuroimmunologia). 136
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients. 131
Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain 129
Electrophysiological study of neurologically asymptomatic HIV1 seropositive patients. 128
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 128
IgM monoclonal gammopathy-associated neuropathies with different IgM specificity. 128
Cerebrospinal fluid analysis and the determination of oligoclonal bands 127
61. Stimulated single-fiber electromyography of the frontal muscle: Normative data using concentric needle 126
Fmoc-protected iminosugar modified asparagine derivatives as building blocks for glycomimetics-containing peptides 125
Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. 125
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope 124
Electroencephalogram and somatosensory evoked potential evaluation for good and poor neurological prognosis after cardiac arrest: A prospective multicenter cohort trial (ProNeCA) 124
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination. 123
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. 123
Anti-myelin associated glycoprotein antibodies recognize HNK-1 epitope on CNS. 122
Efficacy of high-frequency (15 Hz) repetitive transcranial magnetic stimulation (rTMS) of the left premotor cortex/dorsolateral prefrontal cortex in decreasing cocaine intake (the MagneTox study): A study protocol for a randomized placebo-controlled pilot trial 121
Is brain computed tomography combined with somatosensory evoked potentials useful in the prediction of brain death after cardiac arrest? 121
Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a. 120
Neurophysiological and neuroradiological multimodal approach for early poor outcome prediction after cardiac arrest 120
Intrathecal synthesis of anti-HIV antibodies in AIDS patients. 119
The sarcoid anterior horn syndrome. 118
Natural Triterpene Glycosides for Antibody Recognition 118
Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum 116
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis. 116
60. The role of neurophysiology in the diagnosis of incorrect foot support in childhood: Who hides a neurological disease? 116
A Multiple N-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis 115
From the diagnosis to the therapeutic management: cerebral fat embolism, a clinical challenge 115
Authors' comments on two published resuscitation editorials 115
The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study. 113
Infectious causes of multiple sclerosis 113
Muscle-Ultrasound Evaluation in Healthy Paediatric Subjects: Age-Related Normative Data 113
Neurophysiology and neuroimaging accurately predict poor neurological outcome within 24 hours after cardiac arrest: The ProNeCA prospective multicentre prognostication study 113
Cyanobacteria biomagnification and amyotrophic lateral sclerosis. 112
Does an Aberrant Glucosylation Trigger Autoimmunity in Multiple Sclerosis? 112
No association between antibodies to HTLV-1 and polymyositis, rheumatoid arthritis and SLE. 111
64. Transcranial magnetic stimulation in children: Collection of normative values from the lower limbs 111
Intrathecal synthesis of beta-2-microglobulin in multiple sclerosis and aseptic meningo-encephalitis. 110
CONFORMATION-ACTIVITY RELATIONSHIP OF DESIGNED GLYCOPEPTIDES AS SYNTHETIC PROBES FOR THE DETECTION OF AUTOANTIBODIES, BIOMARKERS OF MULTIPLE SCLEROSIS 110
21. Brain computed tomography combined with somatosensory evoked potentials in the prediction of brain death after cardiac arrest 109
Purification of bovine P2 myelin protein with bound lipids. 108
Suppression of experimental allergic encephalomyelitis by retinoic acid. 108
Transthyretin amyloidosis and superficial siderosis of the CNS. 108
Brainstem involvement in Unverricht-Lundborg disease (EPM1): An MRI and (1)H MRS study. 107
Longitudinal evaluation of leukoaraiosis with whole brain ADC histograms. 107
Design And Synthesis of a Novel Potent Myelin Basic Protein Epitope 87-99 Cyclic Analogue: Enhanced Stability and Biological Properties of Mimics Render Them a Potentially New Class of Immunomodulators. 107
Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy. 106
Polymorphonuclear neutral protease activity in multiple sclerosis and other diseases. 106
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients. 106
Small Focused Library of CSF114-type Glycopeptides For the Characterization of Autoantibody Recognition in Multiple Sclerosis 106
IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans. 105
Prognostic value of post-acute EEG in severe disorders of consciousness, using American Clinical Neurophysiology Society terminology 105
Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. 104
Between-laboratory variability in oligoclonal IgG band numbering 103
Intrathecal synthesis of IgG, IgA, IgM and IgD in untreated multiple sclerosis and controls. 103
Intrathecal synthesis of free immunoglobulin light chains and IgM in initial multiple sclerosis. 102
Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: clinicopathological, neurophysiological, and immunological study. 101
Cine-MR imaging of aqueductal CSF flow in normal pressure hydrocephalus syndrome before and after CSF shunt. 101
High-dose intravenous-penicillin in neurosyphilis: effect on intrathecal synthesis of IgG, IgM, IgA and IgD. 101
Early-SEPs'amplitude reduction is reliable for poor-outcome prediction after cardiac arrest? 101
CEREBROSPINAL FLUID PROTEINS IN PATIENTS WITH LEUCOARAIOSIS: POSSIBLE ABNORMALITIES IN BLOOD-BRAIN BARRIER FUNCTION. 101
Suppression of experimental allergic encephalomyelitis by retinoic acid. 101
Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia. 101
Neuromyelitis optica: An update 100
Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats. 99
Antibody Recognition in multiple sclerosis and rett syndrome using a collection of linear and cyclic N-glucosylated antigenic probes 99
Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies. 98
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc) 98
Lipoprotein(a) in the Cerebrospinal Fluid of Neurological Patients with Blood-Cerebrospinal Fluid Barrier Dysfunction. 97
Measurement of free kappa immunoglobulin light chains in the cerebrospinal fluid by a competitive avidin-biotin ELISA. 97
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 97
20. Not only the absence but also amplitude reduction of cortical SEPs predict ominous outcome in comatose patients after cardiac arrest 96
Neurophysiological and neuroradiological test for early poor outcome (Cerebral Performance Categories 3–5) prediction after cardiac arrest: Prospective multicentre prognostication data 95
A COMBINATORIAL APPROACH TOWARDS A DIAGNOSTIC TOOL FOR MS 94
MS PepKit. The First Diagnostic Test to Follow-up Multiple Sclerosis 94
Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome. 94
Studies for Identification of the Minimal Epitope(s) mimicked by the Synthetic Glucopeptide CSF114(Glc) 93
Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis. 93
Glycopeptides of hMOG(30-50) Detect Antibody Response in Multiple Sclerosis and other Neurological Diseases. 92
Oligoclonal bands in tears 92
Interactions between Human Antibodies and Synthetic Conformational Peptide Epitopes: Innovative Approach for Electrochemical Detection of Biomarkers of Multiple Sclerosis at Platinum Electrodes 92
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study 91
Totale 12.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.200 0 0 0 0 294 405 309 399 298 173 264 58
2020/20212.146 158 182 209 206 62 296 75 192 179 282 129 176
2021/20221.357 37 173 114 54 51 53 58 101 61 44 268 343
2022/20233.815 357 735 187 202 297 669 451 188 421 19 123 166
2023/20241.502 60 156 231 80 77 175 99 310 25 83 137 69
2024/20255.822 377 987 594 1.451 2.413 0 0 0 0 0 0 0
Totale 20.797